文献速递糖尿病

整合婴儿代谢物、遗传与胰岛自身免疫特征预测6岁前1型糖尿病

Integration of Infant Metabolite, Genetic, and Islet Autoimmunity Signatures to Predict Type 1 Diabetes by Age 6 Years.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

在TEDDY前瞻性出生队列中,702名在3、6、9月龄均有数据的儿童中11.4%在6岁前进展为1型糖尿病。机器学习模型整合人口学、免疫学、遗传与代谢特征,受试者工作特征曲线下面积为0.84,仅用3和9月龄数据未显著降低曲线下面积,代谢组学在低假阳性率时价值最大。

要点

  • 在TEDDY队列702名儿童中,11.4%于6岁前进展为1型糖尿病。
  • 整合多组学特征的模型预测6岁前1型糖尿病的AUC为0.84。
  • 仅用3和9月龄数据未显著降低AUC,代谢组学在低假阳性率时价值最大。

核心结论

  • 代谢物特征提示婴儿期糖代谢改变,与经典危险因素整合可改善对幼儿期1型糖尿病进展的预测。

研究设计与样本

  • TEDDY前瞻性出生队列纳入有HLA分型的新生儿,来自芬兰、德国、瑞典和美国,儿童来自一般人群或1型糖尿病家族且HLA基因型符合TEDDY入选标准。
  • 702名儿童在3、6、9月龄均有全部数据来源,其中11.4%在6岁前进展为1型糖尿病。
  • 主要结局为按美国糖尿病协会标准诊断的1型糖尿病。

主要发现

  • 机器学习特征选择得到基于人口学、免疫学、遗传和代谢物特征的分类器。
  • 使用全部可用数据评估的模型AUC为0.84。
  • 缩减至仅3和9月龄测量未显著降低AUC。
  • 在低假阳性率下评估准确性时代谢组学价值最大。

关键数值与推荐

  • 模型使用全部可用数据的AUC为0.84。
  • 仅用3和9月龄测量时AUC未显著降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Biomarkers that can accurately predict risk of type 1 diabetes (T1D) in genetically predisposed children can facilitate interventions to delay or prevent the disease. OBJECTIVE: This work aimed to determine if a combination of genetic, immunologic, and metabolic features, measured at infancy, can be used to predict the likelihood that a child will develop T1D by age 6 years. METHODS: Newborns with human leukocyte antigen (HLA) typing were enrolled in the prospective birth cohort of The Environmental Determinants of Diabetes in the Young (TEDDY). TEDDY ascertained children in Finland, Germany, Sweden, and the United States. TEDDY children were either from the general population or from families with T1D with an HLA genotype associated with T1D specific to TEDDY eligibility criteria. From the TEDDY cohort there were 702 children will all data sources measured at ages 3, 6, and 9 months, 11.4% of whom progressed to T1D by age 6 years. The main outcome measure was a diagnosis of T1D as diagnosed by American Diabetes Association criteria. RESULTS: Machine learning-based feature selection yielded classifiers based on disparate demographic, immunologic, genetic, and metabolite features. The accuracy of the model using all available data evaluated by the area under a receiver operating characteristic curve is 0.84. Reducing to only 3- and 9-month measurements did not reduce the area under the curve significantly. Metabolomics had the largest value when evaluating the accuracy at a low false-positive rate. CONCLUSION: The metabolite features identified as important for progression to T1D by age 6 years point to altered sugar metabolism in infancy. Integrating this information with classic risk factors improves prediction of the progression to T1D in early childhood.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Webb-Robertson BM, Nakayasu ES, Frohnert BI, et al. Integration of Infant Metabolite, Genetic, and Islet Autoimmunity Signatures to Predict Type 1 Diabetes by Age 6 Years. J Clin Endocrinol Metab. 2022. PMID: 35468213. doi:10.1210/clinem/dgac225

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。